Rice Hall James & Associates, LLC Repligen Corp Transaction History
Rice Hall James & Associates, LLC
- $1.66 Billion
- Q4 2024
A detailed history of Rice Hall James & Associates, LLC transactions in Repligen Corp stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 15,391 shares of RGEN stock, worth $2.46 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
15,391Holding current value
$2.46 Million% of portfolio
0.13%Shares
7 transactions
Others Institutions Holding RGEN
# of Institutions
476Shares Held
54.5MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.21 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$1.02 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$806 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$260 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$227 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.87B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....